Log in to save to my catalogue

Higher cut-off serum procalcitonin level for sepsis diagnosis in metastatic solid tumor patients

Higher cut-off serum procalcitonin level for sepsis diagnosis in metastatic solid tumor patients

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_518800e828d841e19b69475d5e9124f3

Higher cut-off serum procalcitonin level for sepsis diagnosis in metastatic solid tumor patients

About this item

Full title

Higher cut-off serum procalcitonin level for sepsis diagnosis in metastatic solid tumor patients

Publisher

England: BioMed Central Ltd

Journal title

BMC research notes, 2018-01, Vol.11 (1), p.84-84, Article 84

Language

English

Formats

Publication information

Publisher

England: BioMed Central Ltd

More information

Scope and Contents

Contents

The current study aimed to know procalcitonin levels in patients with metastatic tumor, and to discover the cut-off point for sepsis in this population. A cross-sectional study was conducted with patients with solid tumor. Sepsis and systemic inflammation response syndrome (SIRS) were identified using clinical, laboratory, and microbiological crite...

Alternative Titles

Full title

Higher cut-off serum procalcitonin level for sepsis diagnosis in metastatic solid tumor patients

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_doaj_primary_oai_doaj_org_article_518800e828d841e19b69475d5e9124f3

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_518800e828d841e19b69475d5e9124f3

Other Identifiers

ISSN

1756-0500

E-ISSN

1756-0500

DOI

10.1186/s13104-018-3204-1

How to access this item